---
title: "Sodium Oxybate - Cataplexy And Narcolepsy"
sidebar: mydoc_sidebar
permalink: db09072-mesh-d009290-1.html
toc: false 
---


Path ID: `DB09072_MESH_D009290_1`
{% include image.html url="images/db09072-mesh-d009290-1.png" file="db09072-mesh-d009290-1.png" alt="db09072-mesh-d009290-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D012978 | Sodium oxybate | Drug |
| GO:0016917 | GABA receptor activity | MolecularActivity |
| UniProt:Q9UBS5 | Gamma-aminobutyric acid type B receptor subunit 1 | Protein |
| MESH:D009290 | Cataplexy and narcolepsy | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Sodium Oxybate | INCREASES ACTIVITY OF | Gamma-Aminobutyric Acid Type B Receptor Subunit 1 |
| Gamma-Aminobutyric Acid Type B Receptor Subunit 1 | PARTICIPATES IN | Gaba Receptor Activity |
| Gaba Receptor Activity | TREATS | Cataplexy And Narcolepsy |
|---------|-----------|---------|

Comment: The exact mechanism of action of sodium oxybate for treating narcolepsy and cataplexy is not known but is is hypothesised that its therapeutic effects are due to GABA(B) effects on noradrenergic, dopaminaergic and thalamocorticol neurons.

Reference: 
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200682/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200682/)
  - [https://go.drugbank.com/drugs/DB09072](https://go.drugbank.com/drugs/DB09072)
